Does radical prostatectomy really extend life … at least in Denmark?

A newly published paper in the Scandinavian Journal of Urology comes to the potentially controversial conclusion that “the gain in life expectancy” after surgical treatment by radical prostatectomy “is minimal” for Danish men with prostate cancer compared to the life expectancy of Danish men in general. … READ MORE …

Over-treatment of older men with life expectancies < 10 years

According to a paper newly published in Cancer, “Men aged < 80 years at diagnosis who have life expectancies < 10 years often receive aggressive treatment for low-risk and intermediate-risk prostate cancer, mostly with radiation therapy.” … READ MORE …

Clinical use of nomograms and other tools in prostate cancer counseling and prognosis

Clinical guidelines from such organizations as the American Urological Association (AUA) and the National Comprehensive Cancer Network (NCCN) call for measures designed to improve quality of care and facilitate better treatment decisions for men newly diagnosed with prostate cancer. The degree to which this really happens, however, is not well understood. … READ MORE …

The man who wishes he’d never had the PSA test he demanded

There is an interesting article on Kaiser Health News today discussing the risks associated with “over-testing” of elderly and sometimes very infirm people who are at relatively low risk for specific chronic diseases, including prostate cancer. … READ MORE …

PSA testing in men over 70 years of age — some perspective

A new report in the Journal of Clinical Oncology suggests that — at least between 2000 and 2005 — “excessive PSA screening in elderly men with limited life expectancies” was a significant problem, and may remain so today. … READ MORE …

Health, life expectancy, and management choices for men with localized prostate cancer

When men are initially diagnosed with localized prostate cancer, they face numerous management options — including watchful waiting and active surveillance under appropriate circumstances. In general, physicians tend to recommend treatment if the patient’s reasonable life expectancy is 10 years or more. … READ MORE …

Modeling the life expectancy benefits of active surveillance

An article in today’s issue of the Journal of the American Medical Association, and the accompanying editorial in the same issue, are getting a lot of media attention — despite the fact that the article is “only” a mathematical analysis of the possible quality of life benefits of active surveillance in low-risk patients compared to active intervention. … READ MORE …

Could having a diagnosis of localized prostate cancer increase life expectancy?

In what can only be described as an unexpected finding, a group of German researchers have documented a greater life expectancy for men diagnosed with early stage prostate cancer than for the male population in general, based on data from the Regensburg cancer registry! … READ MORE …

Life expectancy and lifetime risk of prostate cancer mortality

The recently revised National Comprehensive Cancer Network guidelines for the management of prostate cancer emphasize the importance of life expectancy in estimating individual patient risk of prostate cancer mortality — particularly for those patients with low- and very low-risk disease. … READ MORE …

The weekend news reports: April 18, 2009

Today’s news reports deal with:

  • Active surveillance management strategies and outcomes to date
  • Life expectancy and the appropriateness of treatment
  • Penile rehabilitation post-surgery
  • Testosterone replacement therapy in prostate cancer patients … READ MORE …

All the prostate cancer news for Friday, August 8

Today’s news items all focus on issues that are closely connected to the recent and controversial  guidelines issued by the US Preventive Services Task Force:

  • The accuracy of current methods for predicting the likelihood of clinically insignificant (indolent) prostate cancer
  • The management of patients found to have incidental prostate cancer on treatment for benign prostatic hyperplasia (BPH), and
  • The risks of overtreatment of men in their 70s and 80s after a diagnosis of prostate cancer … READ MORE …